Literature DB >> 3076717

Echinococcus multilocularis: in vivo results of therapy with albendazole and praziquantel.

D H Taylor1, D L Morris, K S Richards, D Reffin.   

Abstract

The effects of albendazole and praziquantel on the growth of Echinococcus multilocularis were studied in cotton rats. Albendazole (20 and 50 mg/kg) reduced parasite weight and increased the length of survival of infected animals but viable infection was present after treatment. In an in vitro system albendazole sulphoxide entered cysts of E. multilocularis passively. Praziquantel 100 mg/kg was ineffective but 500 mg/kg significantly inhibited growth. A combination of albendazole and praziquantel was no more effective than either agent alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3076717     DOI: 10.1016/0035-9203(88)90528-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

Review 1.  Anthelminthic agents: some recent developments and their clinical application.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

2.  Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts.

Authors:  S Mahanty; A Paredes; M Marzal; E Gonzalez; S Rodriguez; P Dorny; C Guerra-Giraldez; H H Garcia; T Nash
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

3.  Chemotherapy of experimental Echinococcus multilocularis in jirds.

Authors:  O Vanparijs
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

Review 4.  Diagnosis and treatment of human hydatidosis.

Authors:  H Wen; R R New; P S Craig
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

5.  Comparison of albendazole, mebendazole and praziquantel chemotherapy of Echinococcus multilocularis in a gerbil model.

Authors:  D H Taylor; D L Morris; D Reffin; K S Richards
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.